Global Acne Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Acne Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
Acne Medicine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acne Medicine market is projected to reach US$ 4273.4 million in 2034, increasing from US$ 3616.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Topical and Oral are the major drivers for the industry.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acne Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma
Segment by Type
OTC
Prescription Medicine
Topical
Oral
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acne Medicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Acne Medicine introduction, etc. Acne Medicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Acne Medicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Acne Medicine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acne Medicine market is projected to reach US$ 4273.4 million in 2034, increasing from US$ 3616.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Topical and Oral are the major drivers for the industry.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acne Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma
Segment by Type
OTC
Prescription Medicine
Segment by Application
Topical
Oral
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acne Medicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Acne Medicine introduction, etc. Acne Medicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Acne Medicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices